Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'QUADRUPLE THERAPY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 52 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. de Boer, WA
      A novel therapeutic approach for Helicobacter pylori infection: the bismuth-based triple therapy monocapsule

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    2. Phillips, RH; Whitehead, MW; Doig, LA; Sieniawska, CE; Delves, HT; Thompson, RPH; Powell, JJ
      Is eradication of Helicobacter pylori with colloidal bismuth subcitrate quadruple therapy safe?

      HELICOBACTER
    3. Kaviani, MJ; Malekzadeh, R; Vahedi, H; Sotoudeh, M; Kamalian, N; Amini, M; Massarrat, S
      Various durations of a standard regimen (amoxycillin, metronidazole, colloidal bismuth sub-citrate for 2 weeks or with additional ranitidine for 1 or2 weeks) on eradication of Helicobacter pylori in Iranian peptic ulcer patients. A randomized controlled trial

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    4. Lahaie, R; Farley, A; Dallaire, C; Archambault, A; Fallone, CA; Ponich, T; Hunt, R; Oravec, M; Whitsitt, P; Van Zanten, SV; Marcon, N; Bailey, R; Dumont, A; Nguyen, B; Desrochers, S; Spenard, J
      Bismuth-based quadruple therapy with bismuth subcitrate, metronidazole, tetracycline and omeprazole in the eradication of Helicobacter pylori

      CANADIAN JOURNAL OF GASTROENTEROLOGY
    5. Guslandi, M
      Review article: alternative antibacterial agents for Helicobacter pylori eradication

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    6. Pilotto, A; O'Morain, C
      Treatment of Helicobacter pylori infection

      CURRENT OPINION IN GASTROENTEROLOGY
    7. Hsieh, YH; Lin, HJ; Tseng, GY; Perng, CL; Chang, FY; Lee, SD
      A 3-day anti-Helicobacter pylori therapy is a good alternative for bleeding peptic ulcer patients with Helicobacter pylori infection

      HEPATO-GASTROENTEROLOGY
    8. Luth, S; Teyssen, S; Kolbel, CB; Singer, MV
      4-day triple therapy with rabeprazole, amoxicillin and clarithromycin in the eradication of Helicobacter pylori in patients with peptic ulcer disease- A pilot study

      ZEITSCHRIFT FUR GASTROENTEROLOGIE
    9. Hojo, M; Miwa, H; Nagahara, A; Sato, N
      Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    10. Ungan, M; Kulacoglu, H; Kayhan, B
      Cure rates obtained with five different Helicobacter pylori eradication protocols in patients with duodenal ulcer: A prospective, open-label, randomized study in a primary care setting in Turkey

      CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
    11. Kearney, DJ
      Retreatment of Helicobacter pylori infection after initial treatment failure

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    12. Sherwood, P; Spiller, R
      Could the duration of anti-Helicobacter pylori treatment be shorter?

      DIGESTIVE AND LIVER DISEASE
    13. Moyle, G; Pozniak, A; Opravil, M; Clumeck, N; DelFraissy, JF; Johnson, M; Pelgrom, J; Reynes, J; Vittecoq, D; DeLora, P; Salgo, M; Duff, F
      The SPICE study: 48-week activity of combinations of saquinavir soft gelatin and nelfinavir with and without nucleoside analogues

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    14. Nagahara, A; Miwa, H; Ogawa, K; Kurosawa, A; Ohkura, R; Iida, N; Sato, N
      Addition of metronidazole to rabeprazole-amoxicillin-clarithromycin regimen for Helicobacter pylori infection provides an excellent cure rate with five-day therapy

      HELICOBACTER
    15. Sung, JJY
      Where are we with current therapy?

      HELICOBACTER
    16. Garcia, N; Calvet, X; Gene, E; Campo, R; Brullet, E
      Limited usefulness of a seven-day twice-a-day quadruple therapy

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    17. Chiba, N
      Effects of in vitro antibiotic resistance on treatment: Bismuth containingregimens

      CANADIAN JOURNAL OF GASTROENTEROLOGY
    18. Hentschel, E
      Treatment of Helicobacter pylori infection

      ACTA MEDICA AUSTRIACA
    19. Lai, KC; Hui, WM; Wong, BCY; Hu, WHC; Lam, SK
      Ulcer-healing drugs are required after eradication of Helicobacter pylori in patients with gastric ulcer but not duodenal ulcer haemorrhage

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    20. Catalano, F; Branciforte, G; Catanzaro, R; Cipolla, R; Bentivegna, C; Brogna, A
      Helicobacter pylori-positive duodenal ulcer: three-day antibiotic eradication regimen

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    21. Dore, MP; Leandro, G; Realdi, G; Sepulveda, AR; Graham, DY
      Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy - A meta-analytical approach

      DIGESTIVE DISEASES AND SCIENCES
    22. Treiber, G
      Treating H. pylori shorter than one week - a real future perspective?

      ZEITSCHRIFT FUR GASTROENTEROLOGIE
    23. de Boer, WA
      Topics in Helicobacter pylori infection: Focus on a 'search-and-treat' strategy for ulcer disease

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    24. Bateson, MC
      Helicobacter pylori

      POSTGRADUATE MEDICAL JOURNAL
    25. Sicilia, B; Sierra, E; Lago, A; Villar, M; Garcia, S; Gomollon, F
      High eradication rates in Helicobacter pylori infection in patients with duodenal ulcer who failed previous eradication therapy

      MEDICINA CLINICA
    26. Gomollon, F; Valdeperez, J; Garuz, R; Fuentes, J; Barrera, F; Malo, J; Tirado, M; Simon, MA
      Cost/effectiveness analysis of two strategies for Helicobacter pylori eradication: results of a prospective and randomized study in primary care setting

      MEDICINA CLINICA
    27. van Doorn, LJ; Schneeberger, PM; Nouhan, N; Plaisier, AP; Quint, WGV; de Boer, WA
      Importance of Helicobacter pylori cagA and vacA status for the efficacy ofantibiotic treatment

      GUT
    28. de Boer, WA; van Etten, RJXM; Schneeberger, PM; Tytgat, GNJ
      A single drug for Helicobacter pylori infection: First results with a new bismuth triple monocapsule

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    29. de Boer, WA
      Bismuth triple therapy: still a very important drug regimen for curing Helicobacter pylori infection

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    30. Roghani, HS; Massarrat, S; Pahlewanzadeh, MR; Dashti, M
      Effect of two different doses of metronidazole and tetracycline in bismuthtriple therapy on eradication of Helicobacter pylori and its resistant strains

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    31. Houben, MHMG; Van de Beek, D; Hensen, EF; De Craen, AJM; Rauws, EAJ; Tytgat, GNJ
      A systematic review of Helicobacter pylori eradication therapy - the impact of antimicrobial resistance on eradication rates

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    32. Grimley, CE; Penny, A; O'Sullivan, M; Shebani, M; Lismore, JR; Cross, R; Illing, RC; Loft, DE; Nwokolo, CU
      Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    33. Rinaldi, V; Zullo, A; De Francesco, V; Hassan, C; Winn, S; Stoppino, V; Faleo, D; Attili, AF
      Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    34. Lai, JYL; de Grauw, WJC; de Boer, WA
      Helicobacter treatment with quadruple therapy in primary health care for patients with a history of ulcer disease

      FAMILY PRACTICE
    35. Houben, MHMG; van de Beek, D; Hensen, EF; de Craen, AJM; van't Hoff, BWM; Tytgat, GNJ
      Helicobacter pylori eradication therapy in The Netherlands

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    36. Vyas, SP; Sihorkar, V; Kanaujia, P; Jaitely, V; Venkatesan, N
      Therapeutic and clinical regimens against Helicobacter pylori infections in humans: an overview

      PHARMAZIE
    37. Peitz, U; Hackelsberger, A; Malfertheiner, P
      A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy

      DRUGS
    38. van der Wouden, EJ; Thijs, JC; van Zwet, AA; Sluiter, WJ; Kleibeuker, JH
      The influence of in vitro, nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: A meta-analysis

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    39. OKADA M; OKI K; SHIROTANI T; SEO M; OKABE N; MAEDA K; NISHIMURA H; OHKUMA K; ODA K
      A NEW QUADRUPLE THERAPY FOR THE ERADICATION OF HELICOBACTER-PYLORI - EFFECT OF PRETREATMENT WITH OMEPRAZOLE ON THE CURE RATE

      Journal of gastroenterology
    40. VAIRA D; ALI A; GATTA L; OMORAIN C
      TREATMENT OF HELICOBACTER-PYLORI

      Current opinion in gastroenterology
    41. LADES SD; MALAMOULADA H; ECONOMOU G; TASSIOS PS; RAPTIS SA
      A 3-DAY OCTREOTIDE-CONTAINING HELICOBACTER-PYLORI ERADICATION THERAPYFOR CURE OF PEPTIC-ULCERS

      Hepato-gastroenterology
    42. MEGRAUD F; DOERMANN HP
      CLINICAL RELEVANCE OF RESISTANT STRAINS OF HELICOBACTER-PYLORI - A REVIEW OF CURRENT DATA

      Gut
    43. VANDERHULST RWM; VANDERENDE A; HOMAN A; ROORDA P; DANKERT J; TYTGAT GNJ
      INFLUENCE OF METRONIDAZOLE RESISTANCE ON EFFICACY OF QUADRUPLE THERAPY FOR HELICOBACTER-PYLORI ERADICATION

      Gut
    44. LANGTRY HD; WILDE MI
      OMEPRAZOLE - A REVIEW OF ITS USE IN HELICOBACTER-PYLORI INFECTION, GASTROESOPHAGEAL REFLUX DISEASE AND PEPTIC-ULCERS INDUCED BY NONSTEROIDAL ANTIINFLAMMATORY DRUGS

      Drugs
    45. DEBOER WA; HAECK PWE; OTTEN MH; MULDER CJJ
      OPTIMAL TREATMENT OF HELICOBACTER-PYLORI WITH RANITIDINE BISMUTH CITRATE (RBC) - A RANDOMIZED COMPARISON BETWEEN 2 7-DAY TRIPLE THERAPIES AND A 14-DAY DUAL THERAPY

      The American journal of gastroenterology
    46. TUCCI A; POLI L; PAPARO GF; BOCUS P; TOGLIANI T; MAZZONI C; ORCIONI GF; AGOSTI R; GRIGIONI WF; SOTTILI S; CALETTI G
      WEEKEND THERAPY FOR THE TREATMENT OF HELICOBACTER-PYLORI INFECTION

      The American journal of gastroenterology
    47. KUIPERS EJ; KUSTERS JG; DEBOER WA
      CURRENT THERAPIES OF HELICOBACTER-PYLORI INFECTION

      Bailliere's clinical infectious diseases
    48. RINALDI V; ZULLO A; PUGLIANO F; VALENTE C; DIANA F; ATTILI AF
      THE MANAGEMENT OF FAILED DUAL OR TRIPLE THERAPY FOR HELICOBACTER-PYLORI ERADICATION

      Alimentary pharmacology & therapeutics
    49. DEBOER WA; TYTGAT GNJ
      HOW TO TREAT HELICOBACTER-PYLORI INFECTION - SHOULD TREATMENT STRATEGIES BE BASED ON TESTING BACTERIAL SUSCEPTIBILITY - A PERSONAL VIEWPOINT

      European journal of gastroenterology & hepatology
    50. DEBOER WA
      HOW TO ACHIEVE A NEAR 100-PERCENT CURE RATE FOR HELICOBACTER-PYLORI INFECTION IN PEPTIC-ULCER PATIENTS - A PERSONAL VIEWPOINT

      Journal of clinical gastroenterology
    51. DEBOER WA; DRIESSEN WMM; JANSZ AR; TYTGAT GNJ
      QUADRUPLE THERAPY COMPARED WITH DUAL THERAPY FOR ERADICATION OF HELICOBACTER-PYLORI IN ULCER PATIENTS - RESULTS OF A RANDOMIZED PROSPECTIVESINGLE-CENTER STUDY

      European journal of gastroenterology & hepatology
    52. LAM S; TESSLER HH
      QUADRUPLE THERAPY FOR OCULAR TOXOPLASMOSIS

      Canadian journal of ophthalmology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/05/20 alle ore 12:00:25